Gfg Capital, LLC Novo Nordisk A S Transaction History

Gfg Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$122.71 - $146.91 $11,657 - $13,956	95 Added 4.86%	2,048 $292,000
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $6,024 - $8,019	-59 Reduced 2.93%	1,953 $250,000
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $176,613 - $212,165	2,012 New	2,012 $208,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $17.1 Million - $37.5 Million	188,064 New	188,064 $17.1 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfg Capital, LLC with notifications on news.